| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |